Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs low starting dose enarodustat in non‑dialysis CKD with moderate anemia
ChiCTR2500099582Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enarodustat in anemia of renal disease and chronic kidney disease (CKD) (2 arms), sponsored by Renji Hospital. Primary endpoint: Hemoglobin. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2500099582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099582.